A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases.

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of ...

Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...

and Harry B. Helmsley Charitable Trust ... enable transplanted islet cells to avoid immune rejection and produce insulin without immunosuppression; the potential implications of the data on the ...

Amid increasing demand for power generation, British Columbia's energy minister says the province remains committed to ...

Further experiments showed that activated megakaryocytes produce key molecules that increase the survival of the bone marrow ...

Then, they engineered the cells to produce specific signaling molecules called morphogens. Morphogens are key to cellular development. They determine a cell’s fate based on their concentration.